Sung Lyea Park

431 total citations
20 papers, 351 citations indexed

About

Sung Lyea Park is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sung Lyea Park has authored 20 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Sung Lyea Park's work include Histone Deacetylase Inhibitors Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Sung Lyea Park is often cited by papers focused on Histone Deacetylase Inhibitors Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers). Sung Lyea Park collaborates with scholars based in South Korea, United States and Japan. Sung Lyea Park's co-authors include Sung‐Kwon Moon, Wun‐Jae Kim, Junhui Song, Byung‐Doo Hwang, Seung‐Shick Shin, Sung‐Soo Park, Won Tae Kim, Eo‐Jin Lee, Sook‐Young Lee and Yung Hyun Choi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nutrients.

In The Last Decade

Sung Lyea Park

20 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sung Lyea Park South Korea 12 176 73 50 37 37 20 351
Małgorzata Opydo‐Chanek Poland 13 148 0.8× 41 0.6× 54 1.1× 35 0.9× 44 1.2× 36 366
Yanxia Liu China 15 318 1.8× 106 1.5× 50 1.0× 49 1.3× 34 0.9× 19 499
Sasikumar J. Soumya India 5 246 1.4× 83 1.1× 54 1.1× 40 1.1× 49 1.3× 8 440
Lydia Barré France 12 185 1.1× 36 0.5× 54 1.1× 50 1.4× 26 0.7× 17 368
Xiangshan Ren China 14 261 1.5× 72 1.0× 67 1.3× 31 0.8× 54 1.5× 31 448
Balney Rajitha United States 10 227 1.3× 107 1.5× 95 1.9× 29 0.8× 61 1.6× 12 484
Yu You China 9 252 1.4× 150 2.1× 42 0.8× 40 1.1× 51 1.4× 20 420
Song‐Bin Guo China 11 167 0.9× 71 1.0× 77 1.5× 37 1.0× 42 1.1× 23 354

Countries citing papers authored by Sung Lyea Park

Since Specialization
Citations

This map shows the geographic impact of Sung Lyea Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung Lyea Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung Lyea Park more than expected).

Fields of papers citing papers by Sung Lyea Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung Lyea Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung Lyea Park. The network helps show where Sung Lyea Park may publish in the future.

Co-authorship network of co-authors of Sung Lyea Park

This figure shows the co-authorship network connecting the top 25 collaborators of Sung Lyea Park. A scholar is included among the top collaborators of Sung Lyea Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sung Lyea Park. Sung Lyea Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Junhui, Byung‐Doo Hwang, Sung Lyea Park, et al.. (2024). IL-28A/IL-10Rβ axis promotes angiogenesis via eNOS/AKT signaling and AP-1/NF-κB/MMP-2 network by regulating HSP70-1 expression. Journal of Advanced Research. 73. 247–263. 4 indexed citations
2.
Kim, Gahee, et al.. (2021). Synthesis and biological evaluation of novel purinyl quinazolinone derivatives as PI3Kδ-specific inhibitors for the treatment of hematologic malignancies. Bioorganic & Medicinal Chemistry. 45. 116312–116312. 8 indexed citations
3.
Song, Junhui, Juhee Park, Sung Lyea Park, et al.. (2021). A Novel Cyclic Pentadepsipeptide, N-Methylsansalvamide, Suppresses Angiogenic Responses and Exhibits Antitumor Efficacy against Bladder Cancer. Cancers. 13(2). 191–191. 8 indexed citations
4.
Hwang, Byung‐Doo, Junhui Song, Sung Lyea Park, et al.. (2020). Carnosine Impedes PDGF-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells In Vitro and Sprout Outgrowth Ex Vivo. Nutrients. 12(9). 2697–2697. 7 indexed citations
5.
Shin, Seung‐Shick, Yu‐Jin Park, Byung‐Doo Hwang, et al.. (2019). Triacanthine exerts antitumor effects on bladder cancer in vitro and in vivo. Phytomedicine. 64. 153069–153069. 12 indexed citations
6.
Shin, Seung‐Shick, Byung‐Doo Hwang, Jo‐Won Lee, et al.. (2018). Inhibitory effect of Au@Pt-NSs on proliferation, migration, and invasion of EJ bladder carcinoma cells: involvement of cell cycle regulators, signaling pathways, and transcription factor-mediated MMP-9 expression. International Journal of Nanomedicine. Volume 13. 3295–3310. 9 indexed citations
9.
Park, Sung Lyea, Tae‐Wook Chung, Sangtae Kim, et al.. (2017). HSP70-1 is required for interleukin-5-induced angiogenic responses through eNOS pathway. Scientific Reports. 7(1). 44687–44687. 34 indexed citations
11.
Park, Sung Lyea, et al.. (2016). Esculetin Inhibits VEGF-Induced Angiogenesis BothIn VitroandIn Vivo. The American Journal of Chinese Medicine. 44(1). 61–76. 34 indexed citations
12.
Lee, Se-Jung, Sung Lyea Park, Junhui Song, et al.. (2016). Rosa hybrida extract suppresses vascular smooth muscle cell responses by the targeting of signaling pathways, cell cycle regulation and matrix metalloproteinase-9 expression. International Journal of Molecular Medicine. 37(4). 1119–1126. 7 indexed citations
14.
Song, Junhui, et al.. (2015). Inhibitory effects of fermented extract of Ophiopogon japonicas on thrombin-induced vascular smooth muscle cells. Molecular Medicine Reports. 13(1). 426–432. 6 indexed citations
15.
Park, Sung Lyea, Byung‐Doo Hwang, Sun‐Young Lee, et al.. (2015). p21WAF1 Is Required for Interleukin-16-Induced Migration and Invasion of Vascular Smooth Muscle Cells via the p38MAPK/Sp-1/MMP-9 Pathway. PLoS ONE. 10(11). e0142153–e0142153. 23 indexed citations
17.
Park, Sung Lyea, Wun‐Jae Kim, & Sung‐Kwon Moon. (2014). p21WAF1 mediates the IL-15-induced migration and invasion of human bladder cancer 5637 cells via the ERK1/2/NF-κB/MMP-9 pathway. International Immunopharmacology. 22(1). 59–65. 13 indexed citations
18.
Park, Sung Lyea, Junhui Song, Taiho Kambe, et al.. (2014). EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells. Cellular Signalling. 27(3). 470–478. 26 indexed citations
19.
Park, Sung Lyea, Eo‐Jin Lee, Wun‐Jae Kim, & Sung‐Kwon Moon. (2014). p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-κB binding in the IL-7-induced migration and invasion of 5637 cells. International Journal of Oncology. 44(4). 1349–1356. 27 indexed citations
20.
Park, Sung Lyea, Bo Kyung Lee, Young Ae Kim, Byung Ho Lee, & Yi-Sook Jung. (2013). Inhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells. Biomolecules & Therapeutics. 21(4). 277–283. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026